Latest News and Press Releases
Want to stay updated on the latest news?
-
Inivata Collaborates with Genomics England to Assess Samples and Explore Potential of Liquid Biopsy to Improve Cancer Management and Patient Outcomes Pilot study to test Genomics England...
-
Addario Lung Cancer Medical Research Institute and Inivata Announce Major Study of ctDNA Analysis in Early Stage Lung Cancer InVision(TM) ctDNA liquid biopsy platform to be used to...
-
Inivata Announces Appointment of Dr Jamie Platt as Chief Operations Officer Research Triangle Park, NC and Cambridge, UK, September 8, 2017 -- Inivata, a global clinical cancer genomics company...
-
Inivata Announces Strategic Partnership with Levine Cancer Institute and Formationof the Inivata Knowledge Accumulation Network This network will bring together global leaders in cancer...
-
Inivata Highlights New Clinical Data on the InVision(TM) ctDNA Liquid Biopsy Platform in advanced NSCLC at ASCO 2017 Annual Meeting Study shows InVision to be more sensitive than ddPCR...
-
Inivata, in Collaboration with World- Leading Academic Centers, to Present Promising New Clinical Data on the Utility of the InVision(TM) ctDNA Platform across Multiple Tumor Types at ASCO 2017...
-
Inivata to Present at AACR Annual Meeting 2017 Research Triangle Park, NC and Cambridge, UK, April 3, 2017 -- Inivata, a global clinical cancer genomics company employing a revolutionary...
-
Inivata and Gustave Roussy Publish Positive Results from Prospective Clinical Study in use of ctDNA Liquid Biopsy to Guide Cancer Treatment Publication in Annals of Oncology Shows Benefit of...
-
New Review of ctDNA Liquid Biopsies in Nature Reviews Cancer Co-Authored by Inivata CSO Nitzan Rosenfeld Research Triangle Park, NC and Cambridge, UK 24 February 2017 -- Inivata, a...
-
Research Triangle Park, NC and Cambridge, UK, Dec. 08, 2016 (GLOBE NEWSWIRE) -- Inivata, a global clinical cancer genomics company employing a revolutionary approach to circulating tumor DNA (ctDNA)...